Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024
Apyx Medical (NASDAQ:APYX) announced it will release its third quarter fiscal year 2024 financial results before market opening on November 8th, 2024. The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring a management discussion and Q&A session. The call will be accessible via phone (877-407-9039 for domestic, 201-689-8470 for international callers) with access code 13749764, and through a live webcast on the company's Investor Relations website.
Apyx Medical (NASDAQ:APYX) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre dell'anno fiscale 2024 prima dell'apertura del mercato l'8 novembre 2024. L'azienda ospiterà una conferenza telefonica alle 8:00 del mattino, ora orientale, lo stesso giorno, con una discussione da parte della direzione e una sessione di domande e risposte. La chiamata sarà accessibile tramite telefono (877-407-9039 per le chiamate nazionali, 201-689-8470 per le chiamate internazionali) con codice di accesso 13749764, e attraverso una diretta streaming sul sito web delle Relazioni con gli Investitori dell'azienda.
Apyx Medical (NASDAQ:APYX) anunció que publicará sus resultados financieros del tercer trimestre del año fiscal 2024 antes de la apertura del mercado el 8 de noviembre de 2024. La compañía realizará una conferencia telefónica a las 8:00 a.m. hora del Este el mismo día, con una discusión por parte de la dirección y una sesión de preguntas y respuestas. La llamada estará disponible por teléfono (877-407-9039 para llamadas nacionales, 201-689-8470 para llamadas internacionales) con el código de acceso 13749764, y a través de una transmisión en vivo en el sitio web de Relaciones con Inversores de la compañía.
Apyx Medical (NASDAQ:APYX)는 2024 회계연도 3분기 재무 결과를 2024년 11월 8일 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시로 오전 8시에 경영진과의 논의 및 질의응답 세션이 포함된 전화 회의를 진행할 예정입니다. 이 통화는 전화(국내 877-407-9039, 국제 201-689-8470)로 접속할 수 있으며, 접속 코드 13749764가 필요하고, 회사의 투자자 관계 웹사이트를 통해 생중계로도 접속할 수 있습니다.
Apyx Medical (NASDAQ:APYX) a annoncé qu'il publiera ses résultats financiers du troisième trimestre de l'exercice fiscal 2024 avant l'ouverture du marché le 8 novembre 2024. L'entreprise organisera une conférence téléphonique à 8h00, heure de l'Est, le même jour, comprenant une discussion de la direction et une session de questions et réponses. L'appel sera accessible par téléphone (877-407-9039 pour les appels nationaux, 201-689-8470 pour les appelants internationaux) avec le code d'accès 13749764, et via un webinaire en direct sur le site des Relations avec les Investisseurs de l'entreprise.
Apyx Medical (NASDAQ:APYX) gab bekannt, dass die Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2024 vor der Markteröffnung am 8. November 2024 veröffentlicht werden. Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten, die eine Diskussion der Geschäftsführung und eine Fragerunde umfasst. Der Anruf ist telefonisch erreichbar (877-407-9039 für nationale Anrufer, 201-689-8470 für internationale Anrufer) mit dem Zugangscode 13749764 und über ein Live-Streaming auf der Investor-Relations-Website des Unternehmens.
- None.
- None.
CLEARWATER, Fla., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that financial results for the third quarter of fiscal year 2024 will be released before the market opens on Friday, November 8th.
Management will host a conference call at 8:00 a.m. Eastern Time on November 8th to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 877-407-9039 (or 201-689-8470 for international callers) and provide access code 13749764. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast and via the Investor Relations section of the Company’s website, where it will be archived for future reference.
Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
jfeffer@lifesciadvisors.com
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
FAQ
When will Apyx Medical (APYX) release Q3 2024 earnings?
How can investors join Apyx Medical's (APYX) Q3 2024 earnings call?
What time is Apyx Medical's (APYX) Q3 2024 earnings call?
